Attending physician, at The Affiliated Hospital of Qingdao University, China.
Dr. Xianjuan Zhang is a rising virologist and clinical researcher at the Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University. She earned her Ph.D. and M.Sc. in Pathogen Biology from Qingdao University, dedicating her academic career to investigating the pathogenic mechanisms of Human Cytomegalovirus (HCMV). With a strong foundation in virology, molecular biology, and immune evasion strategies, she has published impactful studies in top-tier journals, including Cellular and Molecular Gastroenterology and Hepatology, PLoS One, and Molecular Neurobiology. Dr. Zhang’s work provides novel insights into virus-host interactions and opens avenues for potential therapeutic interventions. Her research excellence is matched by her dedication to academic service as a peer reviewer for the International Journal of Molecular Sciences. With a strong command of advanced laboratory and bioinformatics tools, Dr. Zhang continues to contribute significantly to the understanding of viral pathogenesis. 📖🧫🔍
Professional Profile
Scopus
🎓 Education
Dr. Xianjuan Zhang pursued both her doctoral and master’s degrees in Pathogen Biology at Qingdao University, China. During her M.Sc. (2016–2019), she developed a strong grasp of virology and immunology fundamentals, laying the groundwork for her more advanced research pursuits. Her Ph.D. studies (2019–2023) were marked by in-depth exploration of Human Cytomegalovirus (HCMV) and its impact on host cells, where she utilized in vivo and in vitro models to unravel molecular and immunological interactions. She mastered a wide range of technical tools including CRISPR, qPCR, siRNA knockdown, Western blotting, and bioinformatics analysis, which enabled her to investigate virus-host mechanisms at a molecular level. Her academic journey reflects not only deep theoretical understanding but also a practical orientation toward translational virology research. Her graduate education laid the foundation for a promising research career focused on infection, immunity, and molecular pathogenesis. 🎓🧪📘
🧑🔬 Experience
Dr. Zhang has amassed valuable academic and professional experience centered on virology and molecular biology. Since 2023, she has served as a peer reviewer for the International Journal of Molecular Sciences, where she evaluates cutting-edge research on host-pathogen interactions, immune modulation, and therapeutic strategies. This role reflects her standing in the scientific community and her expertise in viral pathogenesis. In her research role at the Affiliated Hospital of Qingdao University, Dr. Zhang contributes to multidisciplinary projects aimed at understanding the cellular impact of Human Cytomegalovirus. She collaborates with pathologists, microbiologists, and molecular biologists, enhancing both the quality and translational potential of her research. Her work spans embryonic development, immune suppression, and metabolic syndromes linked to viral infections. Dr. Zhang’s collaborative and peer-reviewed experience demonstrates her capability to contribute both as a researcher and a reviewer in high-impact scientific contexts. 🧬🧫👩⚕️
🔬 Research Interests
Dr. Zhang’s research revolves around the complex interplay between viruses and their hosts, with a primary focus on Human Cytomegalovirus (HCMV). Her studies explore how HCMV modulates host immune systems through evasion mechanisms, particularly focusing on the IL10/STAT3 pathway and antigen presentation suppression in macrophages. She is interested in decoding the molecular mechanisms by which viral proteins interfere with embryonic development, hepatic functions, and neurogenesis, using transgenic mouse models. In addition, Dr. Zhang investigates the role of the gut microbiome and viral infections in metabolic diseases such as hepatic steatosis and gestational diabetes. Her work seeks to identify novel therapeutic targets and enhance understanding of virus-induced pathologies. By leveraging molecular biology, immunological assays, and bioinformatics, Dr. Zhang’s research aims to bridge laboratory findings with clinical applications, offering potential advancements in diagnostics and treatment strategies for viral infections. 🦠🧠💉
🏅 Awards
Dr. Xianjuan Zhang is a nominee for excellence in early-career virology research due to her impactful studies and commitment to scientific advancement. Although still in the early stages of her professional journey, her work has been published in high-impact journals and widely cited by the virology research community. Her contributions to understanding the effects of HCMV on organ development and immune regulation have positioned her as a promising voice in the field. She has been actively engaged in academic service through peer review, demonstrating leadership and responsibility in maintaining scientific integrity. Her nominations stem from both research merit and her application of science to solve critical health issues. With a portfolio of interdisciplinary studies connecting virology, immunology, and metabolic health, Dr. Zhang is a compelling candidate for any early-career research excellence awards. 🏆📚🧪
📚 Top Noted Publications
Dr. Zhang has authored and co-authored several impactful research papers on Human Cytomegalovirus and its pathological mechanisms. Her publication record demonstrates a consistent focus on viral interference with host systems:
1. Zhang X., et al. (2022)
Title: Human Cytomegalovirus-IE2 Affects Embryonic Liver Development and Survival in Transgenic Mouse
Journal: Cellular and Molecular Gastroenterology and Hepatology
Volume: 14(2), Pages: 494–511
DOI: 10.1016/j.jcmgh.2022.01.002
Cited by: 14
Summary: This study investigates the effects of the human cytomegalovirus (HCMV) immediate-early protein 2 (IE2) on embryonic liver development. Using a transgenic mouse model, the researchers demonstrate that IE2 impairs hepatic development, leading to increased embryonic mortality, likely due to disrupted hepatocyte differentiation and survival mechanisms.
2. Zhang X., et al. (2025)
Title: HCMV-IE2 suppresses antigen presentation via IL10/STAT3 pathway
Journal: PLoS One
Volume: 20(5), Article ID: e0322334
DOI: 10.1371/journal.pone.0322334
Cited by: 3
Summary: This paper describes how HCMV-IE2 modulates host immune responses. Specifically, it shows that IE2 inhibits antigen presentation by upregulating IL-10 and activating the STAT3 signaling pathway, leading to immune evasion. This mechanism could contribute to persistent infection and immune suppression.
3. Niu D., Zhang X., et al. (2023)
Title: IE2 disrupts neural progenitor development
Journal: Molecular Neurobiology
Volume: 60(7), Pages: 3883–3897
DOI: 10.1007/s12035-023-03348-2
Cited by: 5
Summary: This study explores the neurodevelopmental impact of HCMV-IE2, showing that IE2 expression disrupts neural progenitor cell proliferation and differentiation. The findings suggest a molecular basis for HCMV-related neurodevelopmental disorders in congenital infections.
4. Zhou X., Zhang X., et al. (2023)
Title: Gut microbiota induces hepatic steatosis
Journal: Scientific Reports
Volume: 13(1), Article ID: 6701
DOI: 10.1038/s41598-023-33829-4
Cited by: 8
Summary: This article investigates the role of gut microbiota in liver fat accumulation. It finds that alterations in microbial composition can induce hepatic steatosis in mice, potentially via modulation of metabolic and inflammatory pathways. Zhang X.’s contribution adds insights into host-microbiome interactions and liver health.
5. Wang Y., Zhang X., et al. (2022)
Title: HCMV and gestational diabetes
Journal: PeerJ
Volume: 10, Article ID: e1293
DOI: 10.7717/peerj.1293
Cited by: 6
Summary: This study explores the association between HCMV infection and gestational diabetes mellitus (GDM). The authors suggest a potential link between HCMV-induced immune dysregulation and glucose intolerance during pregnancy, providing new insight into viral contributions to metabolic disorders.
Conclusion
Dr. Xianjuan Zhang is a promising early-career researcher whose focused contributions to HCMV pathogenesis and host interactions are impactful and published in high-quality journals. Her technical capabilities, publication record, and reviewer role indicate a high level of scientific maturity for her career stage.